Rhelixa

Developer of epigenome analysis technology designed to improve the efficiency and accuracy of life science research and development. The company's technology offers a wide range of solutions, includin...

Healthcare

Tokyo, Japan

Founded 2015

47 employees

Website

Valuation

$17.2M

Market implied

Share Price

N/A

Total Raised

$5.5M

Last Round

N/A

Investors

+9 other investors

View all 9 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Rhelixa's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required